scholarly journals Feasibility Study of the Laparoscopic Approach for Borderline Ovarian Tumors

2013 ◽  
Vol 29 (2) ◽  
pp. 402-407
Author(s):  
Kazu Ueda ◽  
Shin Ohnota ◽  
Keiko Kamoshita ◽  
Momoko Inoue ◽  
Chikage Narui ◽  
...  
Keyword(s):  
Feasibility Study ◽  
Laparoscopic Approach ◽  
Ovarian Tumors ◽  
Borderline Ovarian Tumors

scholarly journals Borderline Ovarian Tumors and Diagnostic Dilemma of Intraoperative Diagnosis: Could Preoperative He4 Assay and ROMA Score Assessment Increase the Frozen Section Accuracy? A Multicenter Case-Control Study

2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Salvatore Gizzo ◽  
Roberto Berretta ◽  
Stefania Di Gangi ◽  
Maria Guido ◽  
Giuliano Carlo Zanni ◽  
...  
Keyword(s):  
Frozen Section ◽  
Menopausal Status ◽  
Laparoscopic Approach ◽  
Preoperative Assessment ◽  
Figo Stage ◽  
Serum Markers ◽  
Ovarian Tumors ◽  
Diagnostic Dilemma ◽  
Additional Information ◽  
Borderline Ovarian Tumors

The aim of our study was to assess the value of a preoperative He4-serum-assay and ROMA-score assessment in improving the accuracy of frozen section histology in the diagnosis of borderline ovarian tumors (BOT). 113 women presenting with a unilateral ovarian mass diagnosed as serous/mucinous BOT at frozen-section-histology (FS) and/or confirmed on final pathology were recruited. Pathologists were informed of the results of preoperative clinical/instrumental assessment of all patients. For Group_A patients, additional information regarding He4, CA125, and ROMA score was available (in Group_B only CA125 was known). The comparison between Group A and Group B in terms of FS accuracy, demonstrated a consensual diagnosis in 62.8% versus 58.6% (P: n.s.), underdiagnosis in 25.6% versus 41.4% (P<0.05), and overdiagnosis in 11.6% versus 0% (P<0.01). Low FS diagnostic accuracy was associated with menopausal status (OR: 2.13), laparoscopic approach (OR: 2.18), mucinous histotype (OR: 2.23), low grading (OR: 1.30), and FIGO stage I (OR: 2.53). Ultrasound detection of papillae (OR: 0.29), septa (OR: 0.39), atypical vascularization (OR: 0.34), serum He4 assay (OR: 0.39), and ROMA score assessment (OR: 0.44) decreased the probability of underdiagnosis. A combined preoperative assessment through serum markers and ultrasonographic features may potentially reduce the risk of underdiagnosis of BOTs on FS while likely increasing the concomitant incidence of false-positive events.

scholarly journals Salpingo-oophorectomy versus cystectomy in patients with borderline ovarian tumors: a systemic review and meta-analysis on postoperative recurrence and fertility

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Peng Wang ◽  
Lei Fang
Keyword(s):  
Surgical Procedures ◽  
Postoperative Recurrence ◽  
Pregnancy Rates ◽  
Ovarian Tumors ◽  
Systemic Review ◽  
Cochrane Library ◽  
Risk Of Recurrence ◽  
Borderline Ovarian Tumors ◽  
Surgical Methods ◽  
Meta Analyses

Abstract Background To compare the postoperative recurrence and fertility in patients with borderline ovarian tumors (BOTs) who underwent different surgical procedures: salpingo-oophorectomy versus cystectomy. Methods Potentially relevant literature from inception to Nov. 06, 2020, were retrieved in databases including Cochrane Library, EMBASE (Ovid), and MEDLINE (Pubmed). We applied the keywords “fertility-sparing surgery,” or “conservative surgery,” or “cystectomy,” or “salpingo-oophorectomy,” or “oophorectomy,” or “adnexectomy,” or “borderline ovarian tumor” for literate searching. Systemic reviews and meta-analyses were performed on the postoperative recurrence rates and pregnancy rates between patients receiving the two different surgical methods. Begger’s methods, Egger’s methods, and funnel plot were used to evaluate the publication bias. Result Among the sixteen eligible studies, the risk of recurrence was evaluated in all studies, and eight studies assessed the postoperative pregnancy rates in the BOT patients. A total of 1839 cases with borderline ovarian tumors were included, in which 697 patients (37.9%) received unilateral salpingo-oophorectomy and 1142 patients (62.1%) underwent unilateral/bilateral cystectomy. Meta-analyses showed that BOT patients with unilateral/bilateral cystectomy had significantly higher recurrence risk (OR=2.02, 95% CI: 1.59-2.57) compared with those receiving unilateral salpingo-oophorectomy. Pooled analysis of four studies further confirmed the higher risk of recurrence in patients with cystectomy (HR=2.00, 95% CI: 1.11-3.58). In addition, no significant difference in postoperative pregnancy rate was found between patients with the two different surgical procedures (OR=0.92, 95% CI: 0.60-1.42). Conclusion Compared with the unilateral/bilateral cystectomy, the unilateral salpingo-oophorectomy significantly reduces the risk of postoperative recurrence in patients with BOT, and it does not reduce the pregnancy of patients after surgery. Trial registration PROSPERO CRD42021238177

Ovulation induction treatment and risk of borderline ovarian tumors

2007 ◽  
Vol 23 (7) ◽  
pp. 373-376 ◽  
Author(s):  
Maite Cusidó ◽  
Rafael Fábregas ◽  
Pere Barris S ◽  
Cecilia Escayola ◽  
Pere Nolsac Barri
Keyword(s):  
Ovulation Induction ◽  
Ovarian Tumors ◽  
Induction Treatment ◽  
Borderline Ovarian Tumors

scholarly journals Minimally invasive treatment options to borderline ovarian tumors

2016 ◽  
Author(s):  
Punita Bhardwaj ◽  
T. K. Das ◽  
S. Batra ◽  
Keyword(s):  
Early Stage ◽  
Treatment Options ◽  
Malignant Potential ◽  
Ovarian Tumors ◽  
Conservative Approach ◽  
Uncertain Malignant Potential ◽  
Invasive Treatment ◽  
Younger Women ◽  
Borderline Ovarian Tumors

Borderline Ovarian tumors are tumors of uncertain malignant potential. They have favour able prognosis. They occur in younger women and present at an early stage. They are difficult to diagnose preoperatively as macroscopic picture is a combination of benign and invasive ovarian tumors. Over the years surgical treatment has changed from radical to conservative approach without overlooking oncologic safety. Follows up is essential. Prolonged follow up (>10 yrs) is required because of later recurrences. Special attention is to be paid to the conserved ovary in follow up.

Experience in the treatment of borderline ovarian tumors

1985 ◽  
Vol 66 (4) ◽  
pp. 303-303
Author(s):  
Z. V. Mavlyutova ◽  
S. L. Galeeva
Keyword(s):  
Ovarian Tumors ◽  
Borderline Ovarian Tumors

It is known that borderline ovarian tumors have not all signs of malignancy, but they are able to implant in the peritoneum.

Surgical Response of Advanced-Stage Borderline Ovarian Tumors to Paclitaxel and Cisplatin Chemotherapy

2000 ◽  
Vol 77 (2) ◽  
pp. 343-344 ◽  
Author(s):  
Gamal H. Eltabbakh ◽  
Alka Srivastava ◽  
Lynda Lee Garafano
Keyword(s):  
Ovarian Tumors ◽  
Advanced Stage ◽  
Borderline Ovarian Tumors
Sign in / Sign up

Export Citation Format

Share Document